D. Agostini, H. Bensadoun, B. Rabut, P. Bott, N. Aide et al., New 3D wholebody PET imaging to detect metastatic renal cancer with 18F-FDG, Journal of Nuc1ear Medicine, vol.42, p.288, 2001.

N. Aide, C. 0. Bottet, P. Bensadoun, H. Regeasse, A. Como-z et al., Efficiency of [ 18 F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT, European Journal of Nuclear Medicine and Molecular Imaging, vol.30, issue.9
DOI : 10.1007/s00259-003-1211-4

T. Akhurst, V. V. Ng, S. Larson, O. Dono-ghue, J. et al., Tumor Burden Assessment with Positron Emission Tomography with [18 F]FDG. Clinical Positron Imagin g, pp.57-65, 2000.

M. Amendol-a, R. Bree, and H. , Small renal cell carcin omas: resolving a diagn ostic dilemma, Radiolo gy, vol.166, pp.637-641, 1988.

H. Anderson, J. Yap, P. Wells, M. Miller, D. Propper et al., Measurement of renal tumour and normal tissue perfusi on using positron emissi on tomography in a phase II clinical trial of razoxane, British Journal of Cancer Ju1, vol.21, issue.892, pp.262-269, 2003.

R. Bachor, F. Kocher, F. Grop-engiesser, S. Reske, and R. Hautmann, Positron emissi on tomography . Introduction of a new procedure in diagnosis of urologie tumors and initial clinical results . Urolo gy Annals, pp.138-180, 1995.

R. Bachor, J. Kotzerk-e, H. Gottfried, E. Brandle, S. Reske et al., Positron emissi on tomography in diagnosis of renal cell carcin oma, UrQ1Qgy Annals, vol.35, pp.146-150, 1996.

H. Bender, A. Schomburg, P. Albers, J. Ruhlmann, and H. Biersack, Possible role of FDG-PET in the evaluation of urologie malignancies, Anticancer Research, vol.17, issue.3B, pp.1655-60, 1997.

A. Blum, T. Ludig, D. Coll, P. Gimel, X. Zhu et al., Bilan préopératoire des cancers du rein en scanner volumique, Journal of Radio1ogy, vol.83, pp.431-50, 2002.

J. Bomanji, D. Costa, and P. Ell, Clin ical l'ole of positron emission tomogra phy in oncology, Lancet Onco logy, vol.200, issue.2, pp.157-164

A. Bomer, K. Langen, H. Herzog, K. Harnacher, V. Muller-mattheis et al., Wh ole-body kinetics and dosimetry of cis-4-[(18)F]fluoro-L-proline. Nuclear Medicine Bio1ogy, pp.287-92, 2001.

P. Bourguet and S. Le-groupe-de-travail, Utilisation de la tomographie par emission de positons au [18F]-FDG en cancérologie. Résultats dans les cancers urologiques, Bulletin du Cancer, pp.80-87, 2003.

A. Brouwers, D. U. , L. 0. Boerman, O. Oyen, W. Steffens et al., Corstens FR 131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study. Nuclear medicine comm unications, pp.229-265, 2002.

A. Brouwers, . Verel-r, J. Van-eerd, G. Visser, M. Steffens et al., Zr-Labeled cG250 Monoclonal Antibody in Nude Rats, Cancer Biotherapy & Radiopharmaceuticals, vol.19, issue.2, pp.155-63, 2004.
DOI : 10.1089/108497804323071922

C. Chang, Y. Shiau, Y. Shen, A. Kao, C. Lin et al., Differentiating Solitary Pulmonary Metastases in Patients with Renal Cell Carcinomas by <sup>18</sup>F-Fluoro-2-Deoxyglucose Positron Emission Tomography ??? A Preliminary Report, Urologia Internationalis, vol.71, issue.3, pp.306-315, 2003.
DOI : 10.1159/000072683

H. Cheow, J. Joseph, and K. Balan, Large renal cell carcinoma isometabolic with normalliver on F -18 FDG PET scan. Clinical Nuclear Medi cine, Au g, vol.29, issue.8, pp.488-90, 2004.

C. Coulange and J. Rambeaud, Cancer du rein de l'adulte. Rapport du congrès de l'AFU 1997. Pro grammes d'Urologie, pp.723-909, 1997.

U. Génétique, Rapport du congrès de l'AFU, 2000.

A. Dana, Imagerie du haut appareil urinaire de l'adulte. Masson éditions., Pari s

D. Il, J. Pruim, P. Elsinga, J. Gen, M. Mensink et al., Visualisation of bladder cancer using (ll)C-cho lin e PET: first clinical experience, European Journal of Nuclear Medicine Mol ecular Imaging, vol.2, issue.10, pp.91283-91291, 2002.

A. De-la-taill-e, P. Meria, and E. Mazeman, Tumeurs de la voie excrétrice urinaire. Encyclopé die Médico-Chirurgicale

S. Führman, L. Lasky, and C. Limas, Prognostic significa nce of mo rphologie pararneters in renal cell ca rc inoma Amer ican Journ al of Surgical Path olo gy, pp.655-663, 1982.

N. Fuj-imoto, A. Sugita, Y. Terasawa, and M. Kato, Observations on the gr owth rate of renal ceII carcinoma, International Journal ofUrology, issue.2, pp.7-8, 1995.

N. Freedman, S. Sundaram, K. Kurdziel, J. Carrasquiiio, M. Whatley et al., Comparison of SUV and Patlak slope for monit oring of cancer therapy using seriai PET scans

S. Gambhir, J. Czernin, J. Schwimmer, D. Silverrnan, R. Coleman et al., A tabulate d summary of the FDG PET literature, Journal ofNucIear Medicine, vol.42, pp.1-93, 2001.

M. Goldberg, W. Mayo-smith, N. Papanicolaou, and A. Fischman, FDG PET characterization of renal masses: Preliminary experience, Clinical Radiology, vol.52, issue.7, pp.510-515, 1997.
DOI : 10.1016/S0009-9260(97)80327-3

S. Hain and M. Maisey, Positron emissi on tomography for urological tum ours. BJU international, pp.159-64, 2003.

J. Harney, R. Wahl, M. Liebert, D. Kuhl, G. Hutchins et al., Uptake of 2-Deoxy, 2-(18F) Fluoro-D-Glucose in Bladder Cancer: Animal Localization and Initial Patient Positron Emission Tomography, The Journal of Urology, vol.145, issue.2, pp.279-83, 1991.
DOI : 10.1016/S0022-5347(17)38314-3

M. Hauser, G. Krestin, and K. Hagspiel, Bilateral solid multifocal intrarenal and perirenal lesions: Differentiation with ultrasonography, computed tomography and magnetic resonance imaging, Clinical Radiology, vol.50, issue.5, pp.288-294, 1995.
DOI : 10.1016/S0009-9260(05)83418-X

R. Heicappell, V. Muller-mattheis, M. Reinhardt, H. Vosberg, C. Gerharz et al., Staging of pelvic Iymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2

. Helenon-0, M. Andre, J. Correas, A. Khairiuone, S. Merran et al., Caractérisation des masses rénales, Journal de Radiol ogie, vol.83, pp.787-802, 2002.

C. Hofer, H. Kubler, R. Hartung, J. Breul, and A. N. , Diagnosis and monitoring of urological tumors using positron emission tomography. European Urolo gy, pp.481-488, 2001.

C. Hoh, M. Seltzer, J. Franklin, J. Dekemion, M. Phelps et al., Positron emissi on tomography in urological oncology, Joumal ofUrolo gy, vol.159, issue.2, pp.347-56, 1998.

H. Jadvar, H. Kherbache, J. Pinski, and P. Conti, Diagnostic role of [F-18]-FDG positron emissi on tomography in restaging renal cell carcinoma, Clinical Nephrology, vol.60, issue.6, pp.39-44, 2003.

R. Jennens, M. Rosenthal, G. Lindeman, and M. Michael, Complete radiological and metabolic response of metastatic rena l cell carcinoma to SU541 6 (semaxanib) in a patient with probable von Hippel-Lindau syndrome. Urolo gie Oncolo gy, pp.193-199, 2004.

J. Vicioso, A. , T. Isidro, V. , C. Delgado et al., The interest of PET (Positron Emission Tomography) for urothelial tumors. Archives Espagnoles d'Urologie, ApL, vol.57, issue.3, pp.337-384, 2004.

D. Kang, R. White, . Jr, J. Zuger, H. Sasser et al., Clinical use of fluorodeoxygluc ose F 18 positron emission tomography for detect ion of renal cell carcin oma, Joumal ofUrology, vol.171, issue.5, pp.1806-1815, 2004.

J. Kawamura, S. Hida, Y. 0. Yonekura, Y. Senda, M. Yamamoto et al., Validity of positron emission tomography (PET) using 2-deoxy-2-[18F]flu oro-Dglucose (FDG) in patients with renal cell carcin oma (preliminary report)

F. Kocher, S. Hauptmann, R. Reske, and S. , Preoperative lymph node staging in patients with kidney and urinary bladder neoplasm

S. Kurl, H. Rytkon-en, P. Farin, M. Ala-opas, and S. Soimakallio, A primary carcin oid tumor of the kidney : a case report and review of the literature. Abdominal Imaging, pp.464-471, 1996.

H. Lang, V. Linder, C. Roy, and D. Jacqmin, Cancer du rein. Encyclopédie Médico-Chirurgicale, pp.96-97
URL : https://hal.archives-ouvertes.fr/inserm-00325579

K. Langen, A. Bomer, V. Muller-mattheis, K. Harnacher, H. Herzog et al., Uptake of cis-4-[18F]fluoro-L-pr oline in urologie tumors, Journal of Nucl ear Medicine, vol.42, issue.5, pp.752-756, 2001.

M. Lodge, R. Carson, J. Carrasquillo, M. Whatley, and S. Libutti, Bacharach SL Parametric images of blood flow in oncology PET studies using [15 0 ] water, Journal of Nuclear Medicine, vol.41, issue.11, pp.1784-92, 2000.

T. Mankoffda, J. Son, P. Gold, J. Eary, D. Guinee et al., Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor., American Journal of Roentgenology, vol.169, issue.4, pp.1049-50, 1997.
DOI : 10.2214/ajr.169.4.9308463

M. Martinelli, D. Townsend, C. Meltzer, and V. Villemagne, 7. Survey of Results of Whole Body Imaging Using the PET/CT at the University of Pittsburgh Medical Center PET Facility, Clinical Positron Imaging, vol.3, issue.4, p.161, 2000.
DOI : 10.1016/S1095-0397(00)00073-X

URL : https://hal.archives-ouvertes.fr/in2p3-00783343

D. Mathews and O. Oz, Positron emission tomography in prostate and renal cell carcinoma, Current Opinion in Urology, vol.12, issue.5, pp.381-386, 2002.
DOI : 10.1097/00042307-200209000-00003

G. Mickisch, J. Carballido, S. Hellsten, and H. Schulze, Guidelines on Renal Cell Cancer, European Urology, vol.40, issue.3, pp.252-255, 2001.
DOI : 10.1159/000049783

F. Mignon and B. Mesurolle, Récidives et disséminations métastatiques du cancer du rein cliniques et implications en imagerie, Journal of Radiology, vol.84, pp.275-284, 2003.

T. Miyauchi, R. Brown, H. Grossma-n, K. Wojno, and R. Wahl, Correlati on between visualization of primary re nal cancer by FDG-PET and histopathological fin dings, Journal of Nuclear Medicine, p.3764, 1996.

H. Miyakita, M. Tokunaga, H. Onda, Y. Usui, H. Kinoshita et al., Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer, International Journal of Urology, vol.37, issue.1, pp.15-23, 2002.
DOI : 10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.3.CO;2-#

F. Montravers, D. Grahek, K. Kerrou, N. Younsi, D. Beco et al., La tomographie par émission de positons aux [18F]-Fluoro -2-desoxyglucose : revue de la littérature et de nos résultats dans les cancers extrapulmonaires, Médecine Nucléaire, vol.23, pp.151-160, 1999.

F. Montravers, D. Grahek, K. Kerrou, N. Younsi, J. Doubl et al., Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera, Journal ofNuclear Medicine, vol.41, issue.1, pp.78-84, 2000.

R. Paul, R. Johansson, P. Kellokumpu-lehtinen, K. Soderstr-om, and L. Kangas, Tumor localization with 18F-2-fluoro-2-deoxy-D-glucose: comparative autoradiography, glucose 6-phosphatase histochemistry, and histology of renally implanted sarcoma of the rat

M. Poggi, N. Patronas, J. Buttman, S. Hewitt, and B. Fuller, Intramedullary spinal cord metastasis from renal cell carcin oma: detecti on by positron emissi on tomography. Clincal Nuclear Medicine, pp.837-846, 2001.

S. Ramdave, G. Thomas, S. Berlangieri, D. Bolton, D. L. Danguy et al., CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMA, The Journal of Urology, vol.166, issue.3, pp.825-855, 2001.
DOI : 10.1016/S0022-5347(05)65845-4

L. Remontet, J. Esteve, A. Bouvi-er, P. Grosclaude, G. Launoy et al., Cancer incidence and mortality in France over the peri od 1978-2 000. Revue d'Epidémiolo gie et de, Santé Publique, vol.5, issue.1, pp.13-30, 2003.

. Rouvière-0, L. Brunereau, D. Lyonnet, and P. Rouleau, Bilan d'extension et surveillance des tumeurs malignes du rein, Journal of Radiolo, vol.83, pp.805-822, 2002.

J. Rozental, R. Levine, M. Mehta, T. Kinsella, A. Levin et al., Early changes in tumor metabolism after treatment: The effects of stereotactic radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.20, issue.5, pp.1053-60, 1991.
DOI : 10.1016/0360-3016(91)90204-H

A. Safaei, R. Figlin, C. Hoh, D. Silverman, M. Seltzer et al., The usefulness of F-18 deoxyglucose wholebody positron emission tomography (PET) for re-staging of renal cell cancer, Clinical Nephrology, vol.57, issue.01, pp.56-62, 2002.
DOI : 10.5414/CNP57056

C. Saussine and H. Lang, Tumeurs de la voie excrétrice supérieure. Revue du Praticien, pp.369-401, 1997.

E. Seto, G. Segall, and M. Terris, Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan, Urology, vol.55, issue.2, p.286, 2000.
DOI : 10.1016/S0090-4295(99)00409-4

. Shvarts-0, K. Han, M. Seltzer, A. Pantuck, and A. Belldegrun, Positron emission tomography in urologie oncology. Cancer Contro l, pp.335-377, 2002.

M. Steffens, P. Mulders, and A. Brouwers, RE: CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMA, The Journal of Urology, vol.168, issue.5, pp.2127-2135, 2002.
DOI : 10.1016/S0022-5347(05)64320-0

B. Shulkin, E. Chang, P. Strouse, and D. Bloom, PET FDG Studies of Wilms Tumors, Journal of Pediatric Hematology/Oncology, vol.19, issue.4, pp.334-342, 1997.
DOI : 10.1097/00043426-199707000-00012

R. Wahl, J. Harney, G. Hutc-hins, and H. Grossman, Imaging of Renal Cancer Using Positron Emission Tomography with 2-Deoxy-2-(18F)-Fluoro-D-Glucose: Pilot Animal and Human Studies, The Journal of Urology, vol.146, issue.6, pp.1470-1474
DOI : 10.1016/S0022-5347(17)38141-7

R. Wahl, G. Hutchins, D. Buchsbaum, M. Liebert, H. Grossman et al., 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xen ografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer, pp.1544-50, 1991.

N. Watanabe, K. O. , H. Shimizu, M. Noguchi, K. Kam-isaki et al., A case of renal pelvic tumor visualized by18F-FDG-PET imaging, Annals of Nuclear Medicine, vol.44, issue.2, pp.161-164, 2004.
DOI : 10.2214/ajr.155.4.2119098

. Wolfg, R. Aigner, U. Humer-fuchs, T. Schwarz, P. Krippl et al., Nierenzellkarzinom-Metastase in einem mikrofollikularen Adenom der Schilddruse, Acta Medica Austriaca, vol.30, issue.4, pp.141-143, 2002.
DOI : 10.1080/003655999750016014

H. Wu, R. Yen, Y. Shen, C. Kao, C. Lin et al., Comparing whole body 18F-2-deoxyglucose positron ennssion tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas -a preliminary report, Journal of cancer research and clinical Onco logy, vol.128, issue.9, pp.503-509, 2002.

S. Yasuda, M. Ide, S. Takagi, and A. Shohtsu, Cancer Screening with Whole-Body FDG PET
DOI : 10.1007/978-3-642-60010-4_6

K. Zimmermann, J. Grunberg, M. Honer, S. Ametamey, and P. Schubiger, Novak-Hofer 1. Targeting of renal carcin oma with 67/64Cu-Iabeled anti-LI-CAM antibody chCE7: selection of copper ligands and PET imaging. Nuc1ear Medicine Biolo gy, pp.417-444, 2003.

H. Zhuang, P. Duarte, M. Pourdehnad, P. Li, and A. Alavi, Standardized uptake value as an unreliable index of renal disease on fluorodeoxygluc ose PET imaging. Clinical Nuc1ear Medicin e, pp.358-60, 2000.

H. Zhuang, D. Yeh, P. Mozley, and A. Alavi, Horseshoe kidney on FDG positron emission tom ographie imaging is easily confused with malignancy. Clinical Nuc1ear Medicin e, pp.35-36, 2001.

A. Zisman, A. Pantuck, M. Bui, J. Said, R. Caliliw et al., LABAZl: A metastatic tumor model for renal cell carcin oma express ing the carbonic anhydrase type 9 tumor antigen. Cancer Research, pp.4952-4961, 2003.